Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6412
    -0.0013 (-0.20%)
     
  • OIL

    81.96
    -0.77 (-0.93%)
     
  • GOLD

    2,390.40
    -7.60 (-0.32%)
     
  • Bitcoin AUD

    101,879.62
    +3,943.40 (+4.03%)
     
  • CMC Crypto 200

    1,334.78
    +22.15 (+1.72%)
     
  • AUD/EUR

    0.6019
    -0.0011 (-0.19%)
     
  • AUD/NZD

    1.0893
    +0.0018 (+0.17%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,829.05
    -48.00 (-0.61%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,718.79
    -118.61 (-0.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Will Johnson & Johnson Become the Next Teva?

Will Johnson & Johnson Become the Next Teva?

Johnson & Johnson has a much broader revenue base than Teva. The company also has a solid presence in the medical devices and consumer healthcare areas.